and Accelerate Growth OAKLAND, Calif., June 17, 2026 — The Clorox Company (NYSE: CLX) today announced a simplified operating structure designed to streamline leadership oversight, align resources to drive the company’s strongest growth opportunities, advance portfolio optimization efforts and support faster execution across the enterprise to improve business performance.

Other Events On May 6, 2026, The Clorox Company (the “Company”) executed an underwriting agreement in connection with the sale of an aggregate principal amount of $550,000,000 of its 4.700% Senior Notes due 2031 (the “2031 Notes”), an aggregate principal amount of $400,000,000 of its 4.950% Senior Notes due 2033 (the “2033 Notes”) and an aggregate principal amount of $550,000,000 of its 5.250% Senior Notes due 2036 (taken together with the 2031 Notes and the 2033 Notes, the “Securities”), in an underwritten registered public offering (the “Underwriting Agreement”).

Organic Volume (4) Health and Wellness —% 1% —% (1)% —% 1% Household — Lifestyle (9) (6) — (3) (9) (6) International — — Total Company (5) —% 1% (1)% —% Nine months ended March 31, 2026 Percentage change versus the year-ago period Reported (GAAP) Net Sales Growth/ (Decrease) Reported Volume Acquisitions & Divestitures (1) Foreign Exchange Impact Price Mix and Other (2) Organic Sales Growth/ (Decrease) Organic Volume (4) Health and Wellness (6)% (5)% —% (1)% (6)% (5)% Household (7) (6) — (1) (7) (6) Lifestyle (13) (11) — (2) (13) (11) International (4) — Total Company (4)(5) (7)% (6)% (1)% —% (1)% (6)% (5)% (1) The divestiture impact is calculated as net sales from the Better Health Vitamins VMS business after the sale date in the nine month year-ago period.